These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

306 related items for PubMed ID: 11899423

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Increased in vitro induced CD4+ and CD8+ T cell IFN-gamma and CD4+ T cell IL-10 production in stable relapsing multiple sclerosis.
    Brod SA, Nelson LD, Khan M, Wolinsky JS.
    Int J Neurosci; 1997 Aug; 90(3-4):187-202. PubMed ID: 9352427
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Intracellular cytokine profile in T-cell subsets of multiple sclerosis patients: different features in primary progressive disease.
    Killestein J, Den Drijver BF, Van der Graaff WL, Uitdehaag BM, Polman CH, Van Lier RA.
    Mult Scler; 2001 Jun; 7(3):145-50. PubMed ID: 11475436
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Interferon-beta therapy reduces CD4+ and CD8+ T-cell reactivity in multiple sclerosis.
    Zafranskaya M, Oschmann P, Engel R, Weishaupt A, van Noort JM, Jomaa H, Eberl M.
    Immunology; 2007 May; 121(1):29-39. PubMed ID: 17239199
    [Abstract] [Full Text] [Related]

  • 7. Analysis of Th1 and Th2 cytokines expressing CD4+ and CD8+ T cells in rheumatoid arthritis by flow cytometry.
    Berner B, Akça D, Jung T, Muller GA, Reuss-Borst MA.
    J Rheumatol; 2000 May; 27(5):1128-35. PubMed ID: 10813277
    [Abstract] [Full Text] [Related]

  • 8. Differential Frequency of CD8+ T Cell Subsets in Multiple Sclerosis Patients with Various Clinical Patterns.
    Salehi Z, Doosti R, Beheshti M, Janzamin E, Sahraian MA, Izad M.
    PLoS One; 2016 May; 11(7):e0159565. PubMed ID: 27467597
    [Abstract] [Full Text] [Related]

  • 9. Abnormal B-cell cytokine responses a trigger of T-cell-mediated disease in MS?
    Bar-Or A, Fawaz L, Fan B, Darlington PJ, Rieger A, Ghorayeb C, Calabresi PA, Waubant E, Hauser SL, Zhang J, Smith CH.
    Ann Neurol; 2010 Apr; 67(4):452-61. PubMed ID: 20437580
    [Abstract] [Full Text] [Related]

  • 10. Time-dependent cytokine deviation toward the Th2 side in Japanese multiple sclerosis patients with interferon beta-1b.
    Ochi H, Feng-Jun M, Osoegawa M, Minohara M, Murai H, Taniwaki T, Kira J.
    J Neurol Sci; 2004 Jul 15; 222(1-2):65-73. PubMed ID: 15240198
    [Abstract] [Full Text] [Related]

  • 11. Cytokine flow cytometry differentiates the clinical status of multiple sclerosis (MS) patients.
    Inogés S, Merino J, Bandrés E, De Castro P, Subirá ML, Sánchez-Ibarrola A.
    Clin Exp Immunol; 1999 Mar 15; 115(3):521-5. PubMed ID: 10193428
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Treatment of multiple sclerosis with Copaxone (COP): Elispot assay detects COP-induced interleukin-4 and interferon-gamma response in blood cells.
    Farina C, Then Bergh F, Albrecht H, Meinl E, Yassouridis A, Neuhaus O, Hohlfeld R.
    Brain; 2001 Apr 15; 124(Pt 4):705-19. PubMed ID: 11287371
    [Abstract] [Full Text] [Related]

  • 15. Th1 cytokine pattern in sarcoidosis is expressed by bronchoalveolar CD4+ and CD8+ T cells.
    Prasse A, Georges CG, Biller H, Hamm H, Matthys H, Luttmann W, Virchow JC.
    Clin Exp Immunol; 2000 Nov 15; 122(2):241-8. PubMed ID: 11091281
    [Abstract] [Full Text] [Related]

  • 16. Characterization of CD4+ and CD8+ T Cell Subsets and Interferon Regulatory Factor 4 (IRF4) in MS Patients Treated with Fingolimod (FTY-720): A Follow-up Study.
    Laribi B, Sahraian MA, Shekarabi M, Emamnejad R, Marzban M, Sadaghiani S, Izad M.
    Iran J Allergy Asthma Immunol; 2018 Aug 12; 17(4):346-360. PubMed ID: 30537798
    [Abstract] [Full Text] [Related]

  • 17. Immune modulation in multiple sclerosis patients treated with the pregnancy hormone estriol.
    Soldan SS, Alvarez Retuerto AI, Sicotte NL, Voskuhl RR.
    J Immunol; 2003 Dec 01; 171(11):6267-74. PubMed ID: 14634144
    [Abstract] [Full Text] [Related]

  • 18. Impact of fingolimod on CD4+ T cell subset and cytokine profile of relapsing remitting multiple sclerosis patients.
    Kürtüncü M, Yılmaz V, Akçay Hİ, Türkoğlu R, Altunrende B, Çınar SA, Ulusoy C, Gündüz T, İçöz S, Kasap M, Çalışkan Z, Ötünç G, Eraksoy M, Tüzün E.
    J Neuroimmunol; 2019 Dec 15; 337():577065. PubMed ID: 31526917
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Differential effects of interferon-β1b on cytokine patterns of CD4+ and CD8+ T cells derived from RRMS and PPMS patients.
    Skrzipek S, Vogelgesang A, Bröker BM, Dressel A.
    Mult Scler; 2012 May 15; 18(5):674-8. PubMed ID: 22025329
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.